Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Evaluation of Gastroesophageal Reflux in Children Born With Esophageal Atresia Using pH and Impedance Monitoring.

Vergouwe FWT, van Wijk MP, Spaander MCW, Bruno MJ, Wijnen RMH, Schnater JM, IJsselstijn H.

J Pediatr Gastroenterol Nutr. 2019 Sep 5. doi: 10.1097/MPG.0000000000002468. [Epub ahead of print]

PMID:
31490855
2.

Yield of Lynch Syndrome Surveillance for Patients With Pathogenic Variants in DNA Mismatch Repair Genes.

Goverde A, Eikenboom EL, Viskil EL, Bruno MJ, Doukas M, Dinjens WNM, Dubbink HJ, van den Ouweland AMW, Hofstra RMW, Wagner A, Spaander MCW.

Clin Gastroenterol Hepatol. 2019 Aug 27. pii: S1542-3565(19)30918-8. doi: 10.1016/j.cgh.2019.08.043. [Epub ahead of print]

PMID:
31470178
3.

Incidence of Interval Colorectal Cancer After Negative Results From First-round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age.

Toes-Zoutendijk E, Kooyker AI, Dekker E, Spaander MCW, Opstal-van Winden AWJ, Ramakers C, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I; Dutch national colorectal cancer screening working group.

Clin Gastroenterol Hepatol. 2019 Aug 20. pii: S1542-3565(19)30896-1. doi: 10.1016/j.cgh.2019.08.021. [Epub ahead of print]

4.

Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.

Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mallant-Hent RC, Lansdorp-Vogelaar I, Bossuyt PMM, Kuipers EJ, Dekker E, Spaander MCW.

Clin Gastroenterol Hepatol. 2019 Aug 13. pii: S1542-3565(19)30890-0. doi: 10.1016/j.cgh.2019.08.015. [Epub ahead of print]

PMID:
31419575
5.

Low Incidence of Advanced Neoplasia in Serrated Polyposis Syndrome After (Sub)total Colectomy: Results of a 5-Year International Prospective Cohort Study.

Bleijenberg AGC, IJspeert JEG, Carballal S, Pellise M, Jung G, van Herwaarden YJ, Bisseling TM, Nagtegaal ID, van Leerdam ME, Spaander MCW, van Lelyveld N, Bessa X, Rodríguez-Alcalde D, Bastiaansen BAJ, de Klaver W, Bemelman WA, Bujanda L, Koornstra JJ, Rivero L, Rodríguez-Moranta F, Balaguer F, Dekker E.

Am J Gastroenterol. 2019 Sep;114(9):1512-1519. doi: 10.14309/ajg.0000000000000339.

PMID:
31403493
6.

Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma.

Suzuki L, Ten Kate FJC, Gotink AW, Stoop H, Doukas M, Nieboer D, Spaander MCW, van Lanschot JJB, van Wijnhoven BPL, Koch AD, Bruno MJ, Looijenga LHJ, Biermann K.

PLoS One. 2019 Jul 8;14(7):e0219494. doi: 10.1371/journal.pone.0219494. eCollection 2019.

7.

Through-the-scope placement of a fully covered metal stent for palliation of malignant dysphagia: a prospective cohort study (with video).

Vermeulen BD, Reijm AN, van der Bogt RD, van Hooft JE, Spaander MCW, Siersema PD.

Gastrointest Endosc. 2019 Jun 29. pii: S0016-5107(19)32018-8. doi: 10.1016/j.gie.2019.06.030. [Epub ahead of print]

PMID:
31265819
8.

Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients.

Faria AVS, Andrade SS, Reijm AN, Spaander MCW, de Maat MPM, Peppelenbosch MP, Ferreira-Halder CV, Fuhler GM.

J Clin Med. 2019 Jun 28;8(7). pii: E936. doi: 10.3390/jcm8070936.

9.

Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.

Schreuders EH, Grobbee EJ, Nieuwenburg SAV, Kapidzic A, van Roon AHC, van Vuuren AJ, Lansdorp-Vogelaar I, Spijker WWJ, Izelaar K, Bruno MJ, Kuipers EJ, Spaander MCW.

Lancet Gastroenterol Hepatol. 2019 Aug;4(8):622-631. doi: 10.1016/S2468-1253(19)30176-1. Epub 2019 Jun 10.

PMID:
31196734
10.

Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis.

Eyck BM, Onstenk BD, Noordman BJ, Nieboer D, Spaander MCW, Valkema R, Lagarde SM, Wijnhoven BPL, van Lanschot JJB.

Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003397. [Epub ahead of print]

PMID:
31188203
11.

Endoscopic grading of gastric intestinal metaplasia: can we do it without pathologists?

Spaander MCW.

Endoscopy. 2019 Jun;51(6):509-510. doi: 10.1055/a-0831-2450. Epub 2019 May 28. No abstract available.

PMID:
31137073
12.

Screening colonoscopy in patients evaluated for liver transplantation: a closer look in a defined population.

Oey RC, Spaander MCW, van Buuren HR, de Man RA.

Hepatology. 2019 May 24. doi: 10.1002/hep.30781. [Epub ahead of print]

PMID:
31127643
13.

HOXA9 mediates and marks premalignant compartment size expansion in colonic adenomas.

Janmaat VT, Liu H, da Silva RA, Wisse PHA, Spaander MCW, Ten Hagen TLM, Smits R, Bruno MJ, Fuhler GM, Peppelenbosch MP.

Carcinogenesis. 2019 Feb 20. pii: bgz038. doi: 10.1093/carcin/bgz038. [Epub ahead of print]

PMID:
31099823
14.

Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years.

Vuik FE, Nieuwenburg SA, Bardou M, Lansdorp-Vogelaar I, Dinis-Ribeiro M, Bento MJ, Zadnik V, Pellisé M, Esteban L, Kaminski MF, Suchanek S, Ngo O, Májek O, Leja M, Kuipers EJ, Spaander MC.

Gut. 2019 Oct;68(10):1820-1826. doi: 10.1136/gutjnl-2018-317592. Epub 2019 May 16.

15.

Achalasia and associated esophageal cancer risk: What lessons can we learn from the molecular analysis of Barrett's-associated adenocarcinoma?

Nesteruk K, Spaander MCW, Leeuwenburgh I, Peppelenbosch MP, Fuhler GM.

Biochim Biophys Acta Rev Cancer. 2019 May 4. pii: S0304-419X(19)30028-9. doi: 10.1016/j.bbcan.2019.04.007. [Epub ahead of print] Review.

16.

Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort study.

Bleijenberg AG, IJspeert JE, van Herwaarden YJ, Carballal S, Pellisé M, Jung G, Bisseling TM, Nagetaal ID, van Leerdam ME, van Lelyveld N, Bessa X, Rodríguez-Moranta F, Bastiaansen B, de Klaver W, Rivero L, Spaander MC, Koornstra JJ, Bujanda L, Balaguer F, Dekker E.

Gut. 2019 Apr 13. pii: gutjnl-2018-318134. doi: 10.1136/gutjnl-2018-318134. [Epub ahead of print]

17.

Effects of Oral Anticoagulant and Aspirin Use on Ability of Fecal Immunochemical Tests to Detect Advanced Neoplasia.

Spaander MCW, Kuipers EJ.

Gastroenterology. 2019 May;156(6):1553-1555. doi: 10.1053/j.gastro.2019.03.031. Epub 2019 Mar 26. No abstract available.

PMID:
30926342
18.

Accuracy of 18F-FDG PET/CT in predicting residual disease after neoadjuvant chemoradiotherapy for esophageal cancer.

Valkema MJ, Noordman BJ, Wijnhoven BPL, Spaander MCW, Biermann K, Lagarde SM, Bennink RJ, Schreurs WMJ, Roef MJ, Hobbelink MGG, Janssen MJR, Graven LH, Van Lanschot JJB, Valkema R.

J Nucl Med. 2019 Mar 15. pii: jnumed.118.224196. doi: 10.2967/jnumed.118.224196. [Epub ahead of print]

PMID:
30877177
19.

Participation and Ease of Use in Colorectal Cancer Screening: A Comparison of 2 Fecal Immunochemical Tests.

de Klerk CM, Wieten E, van der Steen A, Ramakers CR, Kuipers EJ, Hansen BE, Lansdorp-Vogelaar I, Bossuyt PM, Spaander MCW, Dekker E.

Am J Gastroenterol. 2019 Mar;114(3):511-518. doi: 10.14309/ajg.0000000000000148.

PMID:
30789417
20.

The Yield and Safety of Screening Colonoscopy in Patients Evaluated for Liver Transplantation.

Oey RC, van Tilburg L, Erler NS, Metselaar HJ, Spaander MCW, van Buuren HR, de Man RA.

Hepatology. 2019 Jun;69(6):2598-2607. doi: 10.1002/hep.30562. Epub 2019 Apr 6.

21.

Treatment of refractory post-esophagectomy anastomotic esophageal strictures using temporary fully covered esophageal metal stenting compared to repeated bougie dilation: results of a randomized controlled trial.

Kappelle WF, van Hooft JE, Spaander MCW, Vleggaar FP, Bruno MJ, Maluf-Filho F, Bogte A, van Halsema E, Siersema PD.

Endosc Int Open. 2019 Feb;7(2):E178-E185. doi: 10.1055/a-0777-1856. Epub 2019 Jan 18.

22.

Quality Monitoring of a FIT-Based Colorectal Cancer Screening Program.

Toes-Zoutendijk E, Bonfrer JMG, Ramakers C, Thelen M, Spaander MCW, Dekker E, van der Meulen MP, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, van Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I.

Clin Chem. 2019 Mar;65(3):419-426. doi: 10.1373/clinchem.2018.294041. Epub 2019 Jan 16.

PMID:
30651228
23.

High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors.

Rigter LS, Spaander MCW, Aleman BMP, Bisseling TM, Moons LM, Cats A, Lugtenburg PJ, Janus CPM, Petersen EJ, Roesink JM, van der Maazen RWM, Snaebjornsson P, Kuipers EJ, Bruno MJ, Dekker E, Meijer GA, de Boer JP, van Leeuwen FE, van Leerdam ME.

Cancer. 2019 Mar 15;125(6):990-999. doi: 10.1002/cncr.31903. Epub 2018 Dec 18.

24.

Palliation of dysphagia.

van der Bogt RD, Vermeulen BD, Reijm AN, Siersema PD, Spaander MCW.

Best Pract Res Clin Gastroenterol. 2018 Oct - Dec;36-37:97-103. doi: 10.1016/j.bpg.2018.11.010. Epub 2018 Nov 22. Review.

PMID:
30551864
25.

Neoadjuvant chemoradiotherapy for resectable oesophageal cancer.

Eyck BM, van der Wilk BJ, Lagarde SM, Wijnhoven BPL, Valkema R, Spaander MCW, Nuyttens JJME, van der Gaast A, van Lanschot JJB.

Best Pract Res Clin Gastroenterol. 2018 Oct - Dec;36-37:37-44. doi: 10.1016/j.bpg.2018.11.007. Epub 2018 Nov 22. Review.

PMID:
30551855
26.

Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme.

de Klerk CM, Wieten E, Lansdorp-Vogelaar I, Bossuyt PM, Spaander MC, Dekker E.

Lancet Gastroenterol Hepatol. 2019 Feb;4(2):111-118. doi: 10.1016/S2468-1253(18)30319-4. Epub 2018 Nov 27.

PMID:
30497962
27.

Endoscopic ultrasound measurements for detection of residual disease after neoadjuvant chemoradiotherapy for esophageal cancer.

van der Bogt RD, Noordman BJ, Krishnadath KK, Roumans CAM, Schoon EJ, Oostenbrug LE, Siersema PD, Vleggaar FP, van Lanschot JJB, Spaander MCW.

Endoscopy. 2019 Apr;51(4):326-332. doi: 10.1055/a-0795-3220. Epub 2018 Nov 29.

PMID:
30497088
28.

When to stop colonoscopy surveillance in the elderly?

Spaander MCW, Vuik F, Nieuwenburg SAV.

Neth J Med. 2018 Oct;76(8):350. No abstract available.

29.

Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program.

Bronzwaer MES, Depla ACTM, van Lelyveld N, Spanier BWM, Oosterhout YH, van Leerdam ME, Spaander MCW, Dekker E; Dutch Colonoscopy Quality Assurance working group.

Gastrointest Endosc. 2019 Jan;89(1):1-13. doi: 10.1016/j.gie.2018.09.011. Epub 2018 Sep 18. Review.

PMID:
30240879
30.

Towards an Organ-Sparing Approach for Locally Advanced Esophageal Cancer.

van der Wilk BJ, Eyck BM, Spaander MCW, Valkema R, Lagarde SM, Wijnhoven BPL, van Lanschot JJB.

Dig Surg. 2018 Sep 18:1-8. doi: 10.1159/000493435. [Epub ahead of print] Review.

31.

Routine Molecular Analysis for Lynch Syndrome Among Adenomas or Colorectal Cancer Within a National Screening Program.

Goverde A, Wagner A, Bruno MJ, Hofstra RMW, Doukas M, van der Weiden MM, Dubbink HJ, Dinjens WNM, Spaander MCW.

Gastroenterology. 2018 Nov;155(5):1410-1415. doi: 10.1053/j.gastro.2018.07.029. Epub 2018 Jul 29.

PMID:
30063919
32.

Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.

Wieten E, de Klerk CM, van der Steen A, Ramakers CR, Kuipers EJ, Hansen BE, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MCW.

Gastroenterology. 2018 Nov;155(5):1392-1399.e5. doi: 10.1053/j.gastro.2018.07.021. Epub 2018 Jul 25.

PMID:
30055170
33.

Lower Annual Rate of Progression of Short-Segment vs Long-Segment Barrett's Esophagus to Esophageal Adenocarcinoma.

Hamade N, Vennelaganti S, Parasa S, Vennalaganti P, Gaddam S, Spaander MCW, van Olphen SH, Thota PN, Kennedy KF, Bruno MJ, Vargo JJ, Mathur S, Cash BD, Sampliner R, Gupta N, Falk GW, Bansal A, Young PE, Lieberman DA, Sharma P.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):864-868. doi: 10.1016/j.cgh.2018.07.008. Epub 2018 Aug 8.

PMID:
30012433
34.

Risk factors for refractory anastomotic strictures after oesophageal atresia repair: a multicentre study.

Vergouwe FWT, Vlot J, IJsselstijn H, Spaander MCW, van Rosmalen J, Oomen MWN, Hulscher JBF, Dirix M, Bruno MJ, Schurink M, Wijnen RMH; DCEA Study Group.

Arch Dis Child. 2019 Feb;104(2):152-157. doi: 10.1136/archdischild-2017-314710. Epub 2018 Jul 14.

PMID:
30007949
35.

A novel device for intracolonoscopy cleansing of inadequately prepared colonoscopy patients: a feasibility study.

van Keulen KE, Neumann H, Schattenberg JM, van Esch AAJ, Kievit W, Spaander MCW, Siersema PD.

Endoscopy. 2019 Jan;51(1):85-92. doi: 10.1055/a-0632-1927. Epub 2018 Jul 11.

PMID:
29996152
36.

Self-expandable metal stent placement for malignant esophageal strictures - changes in clinical outcomes over time.

Reijm AN, Didden P, Schelling SJC, Siersema PD, Bruno MJ, Spaander MCW.

Endoscopy. 2019 Jan;51(1):18-29. doi: 10.1055/a-0644-2495. Epub 2018 Jul 10.

PMID:
29991071
37.

Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and meta-analysis.

Wieten E, Schreuders EH, Grobbee EJ, Nieboer D, Bramer WM, Lansdorp-Vogelaar I, Bruno MJ, Kuipers EJ, Spaander MCW.

Gut. 2019 May;68(5):873-881. doi: 10.1136/gutjnl-2017-315340. Epub 2018 Jun 22.

PMID:
29934436
38.

Natural History of Barrett's Esophagus.

Kuipers EJ, Spaander MC.

Dig Dis Sci. 2018 Aug;63(8):1997-2004. doi: 10.1007/s10620-018-5161-x. Review.

39.

Fully vs. partially covered selfexpandable metal stent for palliation of malignant esophageal strictures: a randomized trial (the COPAC study).

Didden P, Reijm AN, Erler NS, Wolters LMM, Tang TJ, Ter Borg PCJ, Leeuwenburgh I, Bruno MJ, Spaander MCW.

Endoscopy. 2018 Oct;50(10):961-971. doi: 10.1055/a-0620-8135. Epub 2018 Jun 12.

PMID:
29895072
40.

Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions.

den Hollander WJ, Holster IL, den Hoed CM, Capelle LG, Tang TJ, Anten MP, Prytz-Berset I, Witteman EM, Ter Borg F, Hartog GD, Bruno MJ, Peppelenbosch MP, Lesterhuis W, Doukas M, Kuipers EJ, Spaander MCW.

Gut. 2019 Apr;68(4):585-593. doi: 10.1136/gutjnl-2017-314498. Epub 2018 Jun 6.

PMID:
29875257
41.

Effect of anticoagulants and NSAIDs on accuracy of faecal immunochemical tests (FITs) in colorectal cancer screening: a systematic review and meta-analysis.

Nieuwenburg SAV, Vuik FER, Kruip MJHA, Kuipers EJ, Spaander MCW.

Gut. 2019 May;68(5):866-872. doi: 10.1136/gutjnl-2018-316344. Epub 2018 Jun 5.

PMID:
29871970
42.

Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.

Noordman BJ, Spaander MCW, Valkema R, Wijnhoven BPL, van Berge Henegouwen MI, Shapiro J, Biermann K, van der Gaast A, van Hillegersberg R, Hulshof MCCM, Krishnadath KK, Lagarde SM, Nieuwenhuijzen GAP, Oostenbrug LE, Siersema PD, Schoon EJ, Sosef MN, Steyerberg EW, van Lanschot JJB; SANO study group.

Lancet Oncol. 2018 Jul;19(7):965-974. doi: 10.1016/S1470-2045(18)30201-8. Epub 2018 Jun 1.

PMID:
29861116
43.

Personalized screening for colorectal cancer.

Kuipers EJ, Spaander MC.

Nat Rev Gastroenterol Hepatol. 2018 Jul;15(7):391-392. doi: 10.1038/s41575-018-0015-8. No abstract available.

PMID:
29713023
44.

Optical detection of field cancerization in the buccal mucosa of patients with esophageal cancer.

Bugter O, Spaander MCW, Bruno MJ, Baatenburg de Jong RJ, Amelink A, Robinson DJ.

Clin Transl Gastroenterol. 2018 Apr 30;9(4):152. doi: 10.1038/s41424-018-0023-6.

45.

Improved Progression Prediction in Barrett's Esophagus With Low-grade Dysplasia Using Specific Histologic Criteria.

Ten Kate FJC, Nieboer D, Ten Kate FJW, Doukas M, Bruno MJ, Spaander MCW, Looijenga LHJ, Biermann K; ProBar study group and Palga Group.

Am J Surg Pathol. 2018 Jul;42(7):918-926. doi: 10.1097/PAS.0000000000001066.

PMID:
29697438
46.

Four cancer cases after esophageal atresia repair: Time to start screening the upper gastrointestinal tract.

Vergouwe FW, Gottrand M, Wijnhoven BP, IJsselstijn H, Piessen G, Bruno MJ, Wijnen RM, Spaander MC.

World J Gastroenterol. 2018 Mar 7;24(9):1056-1062. doi: 10.3748/wjg.v24.i9.1056.

47.

Endoscopic screening for gastric cancer: A cost-utility analysis for countries with an intermediate gastric cancer risk.

Areia M, Spaander MC, Kuipers EJ, Dinis-Ribeiro M.

United European Gastroenterol J. 2018 Mar;6(2):192-202. doi: 10.1177/2050640617722902. Epub 2017 Jul 18.

48.

Risk of Oral and Upper Gastrointestinal Cancers in Persons With Positive Results From a Fecal Immunochemical Test in a Colorectal Cancer Screening Program.

van der Vlugt M, Grobbee EJ, Bossuyt PM, Bos ACRK, Kuipers EJ, Lansdorp-Vogelaar I, Spaander MCW, Dekker E.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1237-1243.e2. doi: 10.1016/j.cgh.2018.01.037. Epub 2018 Feb 7.

PMID:
29427732
49.

Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial.

Noordman BJ, Wijnhoven BPL, Lagarde SM, Boonstra JJ, Coene PPLO, Dekker JWT, Doukas M, van der Gaast A, Heisterkamp J, Kouwenhoven EA, Nieuwenhuijzen GAP, Pierie JEN, Rosman C, van Sandick JW, van der Sangen MJC, Sosef MN, Spaander MCW, Valkema R, van der Zaag ES, Steyerberg EW, van Lanschot JJB; SANO-study group.

BMC Cancer. 2018 Feb 6;18(1):142. doi: 10.1186/s12885-018-4034-1.

50.

Surgery for a large tracheoesophageal fistula using extracorporeal membrane oxygenation.

van Drumpt AS, Kroon HM, Grüne F, van Thiel R, Spaander MCW, Wijnhoven BPL, Dos Reis Miranda D.

J Thorac Dis. 2017 Sep;9(9):E735-E738. doi: 10.21037/jtd.2017.08.03.

Supplemental Content

Loading ...
Support Center